Rise and shine, everyone, another busy day is on the way. There is already considerable movement here at the Pharmalot campus, where the short person successfully departed for the local schoolhouse, despite the usual last-minute hurdles and challenges. Such accomplishments call for a cup of stimulation, which is heating in the coffee kettle as we assemble this menu of tidbits for you. However, this is also the signal to get cracking. So on that note, we will wish you a splendid day and offer a reminder that we are happy to accept confidential documents and recordings …

Illinois lawmakers are considering a bill that would guard non-medical switching, which refers to an insurer changing coverage in the middle of a plan year, even though most plan participants are locked in, the Chicago Tribune tells us. The proposed bill would prohibit commercial health insurers from modifying coverage of a drug during the plan year if it has previously approved the drug for a medical condition. It would not prevent plans from requiring pharmacists to give generic substitutions or from adding new drugs for coverage.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • I think it’s wrong to make a person subscribe to your newsletter without even letting a person read a whole article. Is that to much to ask.
    I said to myself let me read this article and if I don’t find anything missing or opinionated in it, I’ll subscribe.
    I won’t now.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy